Eli Lilly and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (53)

View All

Latest Posts

About This Stock More About This Stock
Healthcare (Top 30 Weights) Earnings Estimates And Revisions
Article By: T.J. Hayes
Monday, February 17, 2020 5:44 AM EST
The cumulative 2020 earnings power of these 30 stocks was revised down by -.34% in the past 60 days.
In this article: EW, HCA, HUM, JNJ, LLY, MDT, MRK, PFE, SYK, TMO, UNH, ILMN, AMGN, BIIB, GILD, ISRG, VRTX Also: ABT, AGN, BAX, BDX, BMY, BSX, CI, CNC, CVS, DHR, XLV, ZTS, ABBV, ANTM
Read
Week In Review: Four China Biopharmas Announce $100+ Million Deals In First Week Of 2020
Article By: ChinaBio® Today
Saturday, January 11, 2020 4:11 PM EST
Apollomics of Hangzhou announced a $189 million agreement to develop two GlycoMimetics novel E-selectin-based immunotherapies in China for leukemia. Apollomics will be responsible for developing uproleselan and GMI-1687.
In this article: LLY, GLYC, BPMC, ZLAB
Read
E Boris Bounce; Trump Tripwire
Article By: Vivian Lewis
Sunday, December 15, 2019 5:30 PM EST
Boris Johnson beat the pollsters handily and Britain went into holiday mode. Meanwhile back on Capitol Hill, the on-again-off-again trade deal with China was on again on. The drug price limits bill is dead in the water which will boost pharma stocks.
In this article: BLRX, LLY, RHHBY, EXEL, GSK, BVNRY, CZZ, IRL, MXE, NOK, SLB, MXCHF, NPSNY, TCEHY, HOLI, AQN, PROSY
Read
Week In Review: BeiGene Forms Blockbuster $2.7 Billion Collaboration With Amgen
Article By: ChinaBio® Today
Sunday, November 3, 2019 1:34 AM EST
BeiGene, a Beijing cancer biopharma, announced a blockbuster collaboration with Amgen. I-Mab, a Shanghai biopharma, has filed to IPO; Aesthetic Medical International Holdings, a Shenzhen aesthetics company, completed a $30 million IPO on NASDAQ.
In this article: LLY, AMGN, BGNE, AIH, SNCA
Read
3 Big Drug/Biotech Stocks Set To Beat Q3 Earnings Estimates
Article By: Zacks Investment Research
Saturday, October 12, 2019 10:00 AM EST
Overall, relatively newer drugs have been driving the top line of most of the big shots backed by higher demand - a trend we expect to have benefited third-quarter sales.
In this article: LLY, ALXN, AMGN Also: JNJ
Read
All Posts

PARTNER HEADLINES

Latest Tweets for $LLY

No tweets yet!

$LLY

Comments Status Updates
Stocks For You To Swing-Trade: LLY CMA TTWO
Alpha Stockman • 11/12/2018 8:21:19 AM

These look like some good picks. Liking $CMA, $LLY, $TTWO

1 to 1 of 1 comments